Annual EBITDA
-$74.59 M
-$37.68 M-102.11%
December 31, 2023
Summary
- As of February 7, 2025, AVBP annual EBITDA is -$74.59 million, with the most recent change of -$37.68 million (-102.11%) on December 31, 2023.
- AVBP annual EBITDA is now -102.11% below its all-time high of -$36.91 million, reached on December 31, 2022.
Performance
AVBP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$24.23 M
+$1.47 M+5.70%
September 1, 2024
Summary
- As of February 7, 2025, AVBP quarterly EBITDA is -$24.23 million, with the most recent change of +$1.47 million (+5.70%) on September 1, 2024.
- Over the past year, AVBP quarterly EBITDA has increased by +$1.47 million (+5.70%).
- AVBP quarterly EBITDA is now -132.06% below its all-time high of -$10.44 million, reached on December 1, 2022.
Performance
AVBP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$93.72 M
-$7.52 M-8.72%
September 1, 2024
Summary
- As of February 7, 2025, AVBP TTM EBITDA is -$93.72 million, with the most recent change of -$7.52 million (-8.72%) on September 1, 2024.
- Over the past year, AVBP TTM EBITDA has dropped by -$7.52 million (-8.72%).
- AVBP TTM EBITDA is now -696.41% below its all-time high of -$11.77 million, reached on September 1, 2022.
Performance
AVBP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AVBP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -102.1% | +5.7% | -8.7% |
| 3 y3 years | - | +5.7% | -8.7% |
| 5 y5 years | - | +5.7% | -8.7% |
AVBP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -102.1% | at low | -132.1% | +5.7% | -696.4% | at low |
| 5 y | 5-year | -102.1% | at low | -132.1% | +5.7% | -696.4% | at low |
| alltime | all time | -102.1% | at low | -132.1% | +5.7% | -696.4% | at low |
ArriVent BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.23 M(-5.7%) | -$93.72 M(+8.7%) |
| Jun 2024 | - | -$25.70 M(+24.3%) | -$86.20 M(+3.7%) |
| Mar 2024 | - | -$20.67 M(-10.6%) | -$83.09 M(+11.4%) |
| Dec 2023 | -$74.59 M | -$23.12 M(+38.3%) | -$74.59 M(+20.5%) |
| Sep 2023 | - | -$16.72 M(-26.0%) | -$61.91 M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$22.58 M(+85.5%) | -$56.97 M(+65.7%) |
| Mar 2023 | - | -$12.17 M(+16.6%) | -$34.38 M(+54.8%) |
| Dec 2022 | -$36.91 M | - | - |
| Dec 2022 | - | -$10.44 M(-11.3%) | -$22.21 M(+88.7%) |
| Sep 2022 | - | -$11.77 M | -$11.77 M |
FAQ
- What is ArriVent BioPharma annual EBITDA?
- What is the all time high annual EBITDA for ArriVent BioPharma?
- What is ArriVent BioPharma annual EBITDA year-on-year change?
- What is ArriVent BioPharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly EBITDA year-on-year change?
- What is ArriVent BioPharma TTM EBITDA?
- What is the all time high TTM EBITDA for ArriVent BioPharma?
- What is ArriVent BioPharma TTM EBITDA year-on-year change?
What is ArriVent BioPharma annual EBITDA?
The current annual EBITDA of AVBP is -$74.59 M
What is the all time high annual EBITDA for ArriVent BioPharma?
ArriVent BioPharma all-time high annual EBITDA is -$36.91 M
What is ArriVent BioPharma annual EBITDA year-on-year change?
Over the past year, AVBP annual EBITDA has changed by -$37.68 M (-102.11%)
What is ArriVent BioPharma quarterly EBITDA?
The current quarterly EBITDA of AVBP is -$24.23 M
What is the all time high quarterly EBITDA for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly EBITDA is -$10.44 M
What is ArriVent BioPharma quarterly EBITDA year-on-year change?
Over the past year, AVBP quarterly EBITDA has changed by +$1.47 M (+5.70%)
What is ArriVent BioPharma TTM EBITDA?
The current TTM EBITDA of AVBP is -$93.72 M
What is the all time high TTM EBITDA for ArriVent BioPharma?
ArriVent BioPharma all-time high TTM EBITDA is -$11.77 M
What is ArriVent BioPharma TTM EBITDA year-on-year change?
Over the past year, AVBP TTM EBITDA has changed by -$7.52 M (-8.72%)